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Abstract A sexual dimorphism has been reported for the
adipo-myokine irisin at rest and in response to exercise.
The effects of male and female sex, adiposity, and
gonadectomy on irisin secretion have not been investigated
before. The objective of this study was to elucidate the
effects of sex, adiposity, and gonadectomy in the regulation
of irisin secretion as well as PGC-1a/FNDC5 mRNA and
protein expression. We hypothesized that a lack of female
sex hormones by ovariectomy reduces irisin levels and
inhibits skeletal muscle expression of PGC-1a and FNDC5.
Circulating irisin was measured in vivo in serum samples
of healthy and obese men and women at rest and in
response to acute exercise. The effects of gonadectomy on
serum irisin, PGC-1a and FNDC5 muscle mRNA, and
protein expression were investigated in ovariectomized
(OVX) and orchiectomized (ORX) Wistar rats. Serum iri-
sin at rest was not significantly different between men and
women (lean or obese). However, in response to acute
aerobic exercise, irisin levels increased significantly more
in lean women versus men (p B 0.05). In obese individu-
als, resting irisin concentrations were significantly higher
compared to lean subjects (p B 0.001) and the irisin
response to acute exercise was blunted. Only the lack of
gonadal hormones in OVX but not ORX rats increased
serum irisin levels (p B 0.01) and resulted in significantly
increased body weight (p B 0.01), adipose tissue content
(p B 0.05), muscle FNDC5 mRNA (p B 0.05), and protein
(p B 0.01) expression without altering PGC-1a expression.
Testosterone treatment in ORX rats leads to increased
PGC-1a mRNA content and reduced PGC-1a protein
content without affecting FDNC5 expression or serum
irisin levels. We show that a sexual dimorphism exists for
the acute irisin response to exercise in normal-weight but
not in obese subjects. OVX, which is associated with
increased adiposity and insulin insensitivity, increases
basal FNDC5 expression and serum irisin, without altering
PGC-1a expression. This may be an early sign for meta-
bolic disturbances associated with menopause, such as a
developing irisin resistance or an attempt of the organism
to improve glucose metabolism.
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Introduction
Maintaining energy homeostasis in response to metabolic
perturbations is a major challenge for any multicellular and
complex organism involving multiple and sometimes
redundant physiological responses [1]. The identification of
brown (BAT) and brown-in-white (brite) adipose tissue in
humans [2, 3] has sparked major interests in BAT biology,
with the long-term goal to develop treatment strategies for
metabolic diseases. An elaborate communication network
exists between stimuli such as cold exposure, sympathetic
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activation, and factors secreted from metabolically active
organs such as skeletal muscle (myokines) and adipose
tissue (adipokines), working together to regulate BAT and
brite adipose tissue activity. Adipo-myokines are consid-
ered to mediate many of the beneficial effects of regular
exercise for human health. Although the precise mecha-
nisms are still under investigation, new studies show that
cross-talk between the skeletal muscle and adipose tissue
secretomes with various tissues and organ systems may
play an important role for metabolic function, body weight
regulation, and brain health [4].
The novel adipo-myokine irisin was identified by Bos-
trom et al. in a search for PGC-1a target genes coding for
secreted proteins. They identified the transmembrane pro-
tein FNDC5 (fibronectin [type 3] domain-containing [pro-
tein] 5) as a PGC-1a target, which is cleaved to produce
soluble irisin. They later used adenoviral overexpression of
FNDC5 in the liver of mice to show that transgenic mice
exhibited enhanced oxygen consumption, increased
amounts of white adipose tissue (WAT) browning, and
improved glucose tolerance and insulin sensitivity [5].
There may however be other molecules regulating FNDC5/
irisin other than PGC-1a, since increased PGC-1a after
electrical stimulation of myotubes, exercise mimetics, or
exercise training in vivo does not necessarily lead to an
activation of FNDC5 expression [6–9]. Recently, the
extracellular signal-related kinase (ERK) signaling path-
way has been suggested to control FNDC5 expression
through a non-genomic pathway during neural differenti-
ation of mouse embryonic stem cells [10]. In turn, the
browning effects of irisin have been shown to depend on
the activation of ERK and p38 protein kinase signaling
cascades [11]. Activation of AMPK may also be involved
in FNDC5/irisin activation. FNDC5 expression in skeletal
muscle was shown to be dramatically reduced in resting
muscles of AMPK muscle-specific knockout mice com-
pared to wild-type mice [12]. In response to muscle con-
tractions, AMPK and FNDC5 activation were abolished
even though PGC-1a was increased in wild-type and
knockout mice, suggesting that AMPK may be required for
the regulation of FNDC5 independent of PGC-1a. Inter-
estingly, myostatin knockout mice exhibit not only
increased muscle mass but also browning of WAT, which
was shown to be driven by AMPK [13]. Inhibition of
AMPK significantly reduced PGC1a and FNDC5 expres-
sion [13]. However, other studies do not confirm a critical
role for AMPK in the regulation of irisin secretion.
Treatment with the anti-diabetic drug metformin increased
intramuscular FNDC5 expression, and circulating irisin
and AMPK inhibition did not abolish this effect [14]. The
regulation and the physiological actions of irisin are not yet
fully understood, and further studies are required to
identify putative irisin receptors and study the underlying
mechanisms responsible for activating FNDC5/irisin.
Irisin is predominantly secreted from skeletal muscle,
subcutaneous, and visceral adipose tissue [15, 16]. How-
ever, a recent immunohistochemical study showed that a
number of other tissues such as the liver, brain, testis,
spleen, and the stomach are also able to produce irisin [17].
Numerous studies have investigated the potential factors
triggering irisin secretion. Acute aerobic exercise has been
shown to transiently increase irisin levels in humans [7,
18–20] and mice [21]. A recent study suggests that resis-
tance exercise induces a greater irisin response than
endurance exercise [22]. However, this may be due to the
low endurance exercise intensity performed in this study.
Exercise intensity appears to be a relevant factor for irisin
secretion since no changes in serum irisin levels were
detected after low intensity exercise [8, 23]. In contrast to
acute exercise, chronic exercise training has either no
effects or even lowers resting irisin levels [7]. A recently
published meta-analysis from our group revealed that
chronic exercise training was associated with a moderate
and significant overall effect on decreasing circulating
irisin compared with controls [24]. Exercise training
chronically stimulates numerous signaling molecules and
cascades acting in concert to improve skeletal muscle
substrate uptake and oxidation, such as GLUT-4 expression
and translocation [25, 26], perhaps reducing the need for
elevated resting irisin levels or increasing irisin sensitivity.
Interestingly, shivering due to cold exposure also stimu-
lates irisin secretion proportional to shivering intensity and
similar in magnitude to intense acute exercise [27]. Also,
acute bouts of whole-body vibration exercise transiently
elevate circulating irisin levels [28]. Together, these find-
ings suggest that muscle contraction is the main stimulus
for irisin secretion.
Irrespective of the controversy regarding a point muta-
tion within the start codon of FNDC5 and its consequences
for the secretion of irisin in humans [9], irisin has the
potential to be developed as a pharmacological agent, since
injections of recombinant irisin in obese, diabetic mice led
to significant reductions in body weight, improved glucose
homeostasis [11], and reduced triglyceride levels [11].
Recent data advocate the existence of a sexual dimor-
phism regarding irisin secretion levels at rest, which were
shown to be higher in girls versus boys [29], and in women
versus men [30]. Furthermore, after 3 weeks of sprint
interval training, irisin levels were increased in women and
slightly decreased in men [31]. Our hypothesis that a lack
of female sex hormones by ovariectomy reduces irisin
levels and inhibits skeletal muscle expression of PGC-1a
and FNDC5 is supported by findings of a positive associ-
ation between 17b-estradiol (E2) and irisin [32].
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To date, no data exist on the effects of sex on irisin
levels in response to acute exercise in lean and obese
participants and on the lack of sex hormones by gonadec-
tomy on irisin secretion. Therefore, the aim of this study
was to further elucidate the role of sex, adiposity, and
gonadectomy on circulating irisin levels and skeletal
muscle PGC1a/FNDC5 expression in (I) lean and obese
men and women at rest and in response to acute exercise





Sixteen lean (nine women, 26.3 ± 5.4 years, 65.4 ± 6.5 kg;
seven men, 25.8 ± 6.8 years, 86.4 ± 10.2 kg) and 12 mor-
bidly obese participants (seven women, 52.8 ± 14 years,
128.7 ± 37.1 kg; five men, 54.2 ± 8.1 years, 158.8 ± 26.9
kg) were recruited to perform acute endurance exercise proto-
cols. Lean study participants accomplished a step-wise incre-
mental exercise trial until exhaustion on a cycling ergometer
(Excalibur Sport, Netherlands). A modified treadmill walking
protocol was used for obese participants, which led to
exhaustion in approximately 10 min. Venous bloodwas drawn
prior to and immediately post exercise in obese and additionally
10 and 60 min post exercise in lean participants. Capillary
blood samples (20 ll) were taken from the hyperemized ear
lobe and analyzed for blood lactate (Biosen S-Line, EKF;
Barsleben, Germany). Serum samples were obtained by cen-
trifugation for 10 minat 25009g andwere stored at-80 Cfor
subsequent analysis. All experiments involving human partic-
ipants were conducted with ethical approval from the ethics
committee at Ulm University. All study participants gave
written informed consent after the study procedures and
objectives were explained.
Animals and tissue preparation
Male and female Wistar rats (n = 6/group) were kept at
constant room temperature (20 ± 1 C), relative humidity
(50–80 %), and illumination (12 h light/dark cycles).
Water and a soybean free diet (Ssniff Sm R/M-H, 10 mm,
phytoestrogen-free, Soest, Germany) were provided ad li-
bitum. Before the start of experimental procedures, animals
were either left intact (intact) or were ovariectomized
(OVX), orchiectomized (ORX), or sham operated (sham)
via the dorsal route. A subset of ORX rats was treated with
testosterone propionate (1 mg/kg BW) for 10 days after
7 days of hormonal decline. Animals were sacrificed by
decapitation after light anesthesia with CO2 inhalation at
the age of 18 weeks (female Wistar rats) or 14 weeks
(male Wistar rats). Skeletal muscle (M. soleus) and intra-
abdominal visceral fat (retroperitoneal and mesenteric fat
pads) were dissected, wet weights were recorded, and tis-
sues were directly frozen in liquid nitrogen until further
analysis. All animal experimentation described in the
manuscript was conducted after ethics approval in accord
with accepted standards of humane animal care.
Analytical methods
Irisin measurement
Irisin concentrations in serum were determined using a
competitive, commercially available ELISA kit (Phoenix,
EK-067-52). The linear range for this assay is
0.066–1024 ng/ml (intra-assay variation 4–6 %, inter-as-
say variation 8–10 %). Absorbance was measured using a
spectrophotometer at 450 nm wavelength (Thermo Scien-
tific, Multiskan FC).
qPCR experiments
Total RNA from frozen muscle was extracted from each
animal (n = 6 animals/group) using the Qiagen Tissue
Ruptor in combination with the Qiagen RNeasy Fibrous
Tissue Mini Kit. RNA was quantified by spectrophotome-
try (NanoDrop TM 1000, Thermo Scientific, USA), and
cDNA was synthesized from 1 lg RNA using a Reverse
Transcription System (QuantiTect Reverse Transcription,
Qiagen). qPCR was performed using the QuantiFast SYBR
Green PCR Kit (Qiagen, Germany) on a Lightcycler 480
(Roche) platform. QuantiTect Primer Assays (Qiagen)
were used to detect PGC-1a and FNDC5 in rat skeletal
muscle. Relative expressions of target genes from three
independent PCR experiments were calculated after nor-
malization to the endogenous reference gene RPL13
according to the DDCT method.
Protein expression
Proteins were isolated from frozen muscle samples after
disruption and homogenization (Qiagen TissueRuptor)
followed by sonification (Bandelin, Sonoplus) using RIPA
buffer (25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1 % NP-
40, 1 % sodium deoxycholate, 0.1 % SDS, Pierce) plus
protease inhibitor (cOmplete, Mini, EDTA-free tablets,
Roche). Protein concentration was determined by the BCA
assay (Pierce). Protein lysates (n = 6 animals/group
pooled) were subjected to SDS–polyacrylamide gel elec-
trophoresis (PAGE, Bio-Rad) and blotted onto a PVDF
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membrane (Amersham) for 45 min (300 mA). Membranes
were incubated with rabbit anti-PGC-1a (1:1000; Milli-
pore), rabbit FNDC5 (1:500; Abgent), and mouse b-Actin
(1:5000; Calbiochem) primary antibodies at 4 C over-
night. After a 1-h incubation period with secondary anti-
rabbit (1:3500; Promega) or anti-mouse (1:10,000; Cal-
biochem) HRP-conjugated antibody, specific proteins were
visualized with the ECL detection system (Amersham).
Three independent blots were quantified by densitometry
(Image J software), and results were expressed as signal
intensities relative to the expression of the endogenous
reference protein b-Actin.
Statistical analysis
Statistical significance of differences were calculated using
either two-way ANOVA with Tukey’s multiple compar-
ison test to determine the effects of sex and exercise or one-
way ANOVA to assess the effects of hormone status
between groups (GraphPad Prism, 6.0). Statistical signifi-
cance was established at p B 0.05.
Results
Sexual dimorphism in the irisin response to acute
endurance exercise in normal-weight
but not in obese subjects
Differences in irisin concentrations at rest between men
and women were non-significant, neither in lean individ-
uals (74.38 vs. 84.02 ng/ml) nor in obese persons
(101.42 ± 19.2 vs. 101.97 ± 11.0 ng/ml). However, irisin
levels increased significantly after acute cycling exercise
until exhaustion in lean men (p B 0.05) and women
(p B 0.01) (Fig. 1a), while no significant change was
observed after exercise in neither obese men (101.4 pre-ex
vs. 102.1 ng/ml post-ex) nor women (102.0 pre-ex vs.
105.0 ng/ml post-ex) (Fig. 1b). Elevated irisin levels in
lean subjects returned to baseline levels 100 (men) or 600
(women) after exercise (Fig. 1a). There was a significant
main effect of sex and time (p B 0.05) with a greater
increase in irisin concentrations and slower return to
baseline levels after exercise in lean women versus men.
Furthermore, a significant difference in the concentration
of irisin between obese versus lean men and women was
detected at rest (p B 0.001). Resting irisin concentrations
were approximately 30 % higher in obese versus lean
individuals (Fig. 1c).
Fig. 1 Effects of sex and obesity on resting and exercise-induced
irisin secretion. Circulating irisin concentrations increase in normal-
weight (a) but not in obese men and women (b) immediately after
acute aerobic exercise. Resting irisin levels are higher in obese versus
normal-weight participants (c). a *p B 0.05 women versus men
immediately after exercise, §p B 0.01 women 00 vs rest, ?p B 0.05
men 00 versus rest and women 100 versus rest, c ***p B 0.001 obese
versus normal-weight subjects at rest
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Ovariectomy (OVX) increases body weight, visceral
fat content, and serum irisin levels
Body weight was significantly higher in OVX versus sham-
operated Wistar rats (Fig. 2a, p B 0.01). Relative to body
weight, visceral fat content (Fig. 2b, p B 0.05) was sig-
nificantly higher and muscle mass (Fig. 2c, p B 0.01)
significantly lower in OVX versus sham rats. Resting irisin
levels were *25 % higher in female OVX rats compared
with sham rats (Fig. 2d, p B 0.01).
Orchiectomy (ORX) does not affect serum irisin
levels nor phenotype
ORX in male Wistar rats was not associated with signifi-
cant changes in body weight, visceral body fat content,
skeletal muscle mass, or serum irisin levels compared to
gonad intact rats (Fig. 3).
Ovariectomy (OVX) increases FNDC5 mRNA
and protein content
Resting PGC-1a mRNA (Fig. 4a) or protein (Fig. 4b)
expression was not significantly different in skeletal mus-
cle of OVX compared to sham-operated rats. In contrast,
FNDC5 mRNA (Fig. 4c, *p B 0.05) and protein (Fig. 4d,
**p B 0.01) content was significantly higher in skeletal
muscle of OVX versus sham rats.
Increased PGC-1a mRNA and reduced protein
levels in skeletal muscle of testosterone treated
orchiectomized rats
PGC-1a mRNA content was significantly elevated in
skeletal muscle of ORX ? TP treated male rats compared
to gonad intact male rats (Fig. 5a, *p B 0.05). In contrast
to elevated mRNA levels, protein expression was signifi-
cantly reduced in ORX ? TP versus ORX (Fig. 5c,
***p B 0.001) and versus intact (**p B 0.01). No signif-
icant differences were found between groups for FNDC5
mRNA (Fig. 5b) or protein content (Fig. 5d).
Discussion
Recent studies suggest that there may be a sexual dimor-
phism in the regulation of irisin secretion. While our results
and those of Scalzo et al. indicate no sex-specific differ-
ences for absolute resting irisin levels in healthy adults
[31], other studies show that resting irisin was significantly
higher in girls versus boys (12 ± 3 years old) and in
healthy young (20 ± 0.1 years old) women versus men
after adjusting for lean body mass [30]. Our data reveal
however that there is a sexual dimorphism in the transient
increase of irisin in response to acute, high-intensity
endurance exercise: serum irisin concentrations were sig-
nificantly higher immediately after intense endurance
exercise in healthy, lean women versus men, suggesting
that estrogens may play a role in the transient irisin
Fig. 2 Effects of ovariectomy
(OVX) on body weight, visceral
fat content, muscle mass and
serum irisin levels. Body weight
(a), visceral body fat (b),
muscle mass relative to body
weight (c) and serum irisin
levels (d) in sham-operated
versus ovariectomized (OVX)
Wistar rats. *p B 0.05 and
**p B 0.01 OVX versus sham
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Fig. 3 Effects of orchiectomy
(ORX) on body weight, visceral
fat content, muscle mass, and
serum irisin levels. Body weight
(a), visceral body fat (b),
muscle mass relative to body
weight (c), and serum irisin
levels (d) in orchiectomized
(ORX) versus
ORX ? testosterone propionate
(TP) treated and gonad intact
(intact) male Wistar rats,
n = 6/group
Fig. 4 Ovariectomy (OVX)
increases FNDC5 mRNA and
protein content. mRNA
expression of PGC-1a (a) and
FNDC5 (c). Western blot and
densitometric analysis of PGC-
1a (b) and FNDC5 (d) in
skeletal muscle of sham-
operated and ovariectomized
(OVX) female Wistar rats,
n = 6/group. *p B 0.05 OVX
versus sham, **p B 0.01 OVX
versus sham
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increase. This is in line with findings by Scalzo et al.
showing that 3 weeks of sprint interval training resulted in
increased resting irisin levels in women but reduced levels
in men 48 h after the last exercise bout [31]. Exercise
intensity appears to be an important factor for irisin
secretion, since no sex differences in irisin responses have
been detected during low intensity acute endurance exer-
cise [19]. Irisin concentrations increased 20 % in both men
and women during moderate intensity endurance exercise
and returned to baseline at the end of the exercise session
[19]. In contrast to the acute elevations in serum irisin
concentrations observed during and after intense endurance
and resistance exercise [7, 20, 22, 23], resting irisin levels
are either remained unchanged or reduced after chronic
exercise training [7, 24]. This may be due to enhanced
sensitivity of irisin action and/or a reduced need for irisin
secretion after regular training due to the activation of
other adaptive mechanisms stimulating numerous skeletal
muscle signaling molecules responsible for mitochondrial
biogenesis and enhanced glucose uptake, such as PGC-1a,
TFAM, and GLUT-4 expression and translocation [25, 26,
33].
Interestingly, our results indicate that the sexually
dimorphic response of irisin to acute exercise, observable
in lean individuals, was blunted in severely obese (BMI
[45) men and women. This outcome supports findings by
Winn and colleagues, also demonstrating that irisin was not
responsive to acute or chronic exercise in obese adults [34].
Moreover, in accordance with other studies [20, 35], total
irisin concentrations at rest were higher in obese versus
lean individuals, indicating that irisin is chronically ele-
vated in obese people due to altered metabolic signaling
associated with adiposity. However, even though exercise-
induced changes may be small relative to the high baseline
levels in obese individuals, even small irisin increases after
exercise may still be biologically relevant for metabolic
function. Furthermore, exercise has been shown to be able
to increase irisin in subjects with metabolic syndrome [36].
Gonadectomy, adiposity, and irisin
Huh et al. showed that a significant positive correlation
exists between circulating irisin and estradiol [32] leading
us to hypothesize that removal of estradiol by ovariectomy
reduces irisin secretion. We used animal models mimick-
ing the age-related sex hormone decline during menopause
(ovariectomy, OVX) and andropause (orchiectomy, ORX)
to study the effects of gonadectomy on irisin secretion.
Declining female sex hormone in OVX rats levels mirror a
pre-diabetic status [37] and are generally associated with
increased adiposity and metabolic dysfunction [38]. Our
results confirm that a lack of ovarian sex hormones as a
result of OVX is associated with significant increases in
body weight, of which increased visceral fat content is the
Fig. 5 Effects of orchiectomy
(ORX) on skeletal muscle PGC-
1a and FNDC5 mRNA and
protein content. Gene
expression of PGC-1a (a) and
FNDC5 (b). Western blot and
densitometric analysis of PGC-
1a (c) and FNDC5 (d) in
skeletal muscle from ORX,
ORX ? TP and intact male rats,
n = 6/group. a *p B 0.05
ORX ? TP versus intact,
c ***p B 0.001 ORX versus
ORX ? TP, **p B 0.01
ORX ? TP versus intact
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major determinant. The amount of muscle mass relative to
body weight was significantly reduced after OVX. In
contrast, removal of male gonadal steroids in ORX rats had
no significant effects on body weight, visceral fat content,
or muscle mass. Contrary to our hypothesis, stating that
particularly the removal of ovarian hormones would result
in decreased irisin concentrations, significantly increased
serum irisin levels were detected in OVX but not in ORX
rats. This may be due to the increased adiposity and
metabolic alterations associated with OVX and may be
part of a complex compensatory mechanism in the early
post-menopausal, pre-diabetic state to increase energy
expenditure.
Cross-sectional studies have revealed that irisin con-
centrations were positively associated with biceps cir-
cumference, as a surrogate marker for muscle mass [32].
Rat skeletal muscle secretes approximately 60 % more
irisin than visceral adipose tissue [16] and human FNDC5
expression is 200-fold higher in skeletal muscle compared
to adipose tissue [15, 16]. However, even though muscle
mass was shown to be the strongest predictor of irisin
levels [30, 32], irisin was not significantly reduced in sar-
copenia patients [39]. This finding underlines the quanti-
tative contribution of adipose tissue to irisin secretion,
since sarcopenia is often associated with obesity known as
sarcopenic obesity.
Our results did not confirm our hypothesis that removal
of estradiol in OVX rats would reduce irisin secretion. In
contrast, OVX was associated with significantly higher
irisin level, suggesting that the adiposity-related molecular
pathways associated with OVX stimulate chronic eleva-
tions in serum irisin. The type of adipose tissue may be
relevant for irisin secretion patterns. Irisin was detected in
the secretomes of both visceral and subcutaneous adipose
tissue, and interestingly, subcutaneous adipose tissue
secretes 40 % more FNDC5/irisin than visceral adipose
tissue [16].
Effects of gonadectomy on the regulation
of the irisin signaling pathway: PGC-1a/FNDC5
expression
To elucidate the effects of gonadectomy on the signaling
cascades leading to irisin concentrations, we investigated
the effects of OVX/ORX on skeletal muscle PGC-1a and
FNDC5 mRNA and protein levels. Our results indicate that
while serum irisin and muscle FNDC5 are elevated at rest
in ovariectomized female rats, PGC-1a expression was
unaltered. Also, testosterone treatment in orchiectomized
male rats significantly increased PGC-1a mRNA and
reduced PGC-1a protein content without significantly
altering FNDC5 mRNA or protein content. This implies
that other, yet unidentified upstream molecules may be
involved in activating FNDC5/irisin. Other studies using
electrical stimulation of myotubes, exercise mimetics or
exercise training in vivo have also shown PGC-1a upreg-
ulation does not necessarily lead to an activation of FNDC5
expression [6–9]. Recently, the extracellular signal-related
kinase (ERK) signaling pathway has been suggested to
control FNDC5 expression through a non-genomic path-
way [10]. In addition, AMPK may be involved in the
activation of FNDC5. FNDC5 expression in skeletal mus-
cle was shown to be dramatically reduced in resting mus-
cles of AMPK muscle-specific knockout mice compared to
wild-type mice [12]. In response to muscle contractions,
AMPK and FNDC5 activations were abolished even
though PGC-1a was increased in wild-type and knockout
mice, suggesting that AMPK is required for the regulation
of FNDC5. Our results do not confirm a direct involvement
of the PGC-1a/FNDC5/irisin pathway in response to
gonadectomy, and more studies are needed to study the
regulation of FNDC5/irisin in response to exercise or
hormonal alterations.
Summary
Taken together, we show that the transient increase in
serum irisin after acute exercise is stronger in lean women
compared to men, supporting findings of a positive asso-
ciation between estradiol and irisin [32]. Chronic eleva-
tions of irisin in obese versus lean individuals at rest may
be mediated by altered metabolic signaling associated with
adiposity; however, the exercise response was severely
blunted in obese men and women. Exercise can be con-
sidered as a non-pharmacological treatment able to tran-
siently increase serum irisin. Future studies should
determine whether long-term exercise training combined
with weight loss in obese individuals enhances the irisin
response to exercise.
Lack of female sex hormones in OVX rats leads to
adiposity and metabolic derailment, which is associated
with increased circulatory irisin and skeletal muscle
FNDC5 expression independent of PGC-1a expression.
These findings point toward a compensatory mechanism in
the early post-menopausal, pre-diabetic, and possibly ‘iri-
sin-resistant’ state, where increased amounts of irisin are
secreted in an attempt to increase energy expenditure by
browning of WAT or other yet unidentified effects in
skeletal muscle.
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